HSP90 is a target protein for ubiquitination in Giardia intestinalis

被引:0
|
作者
Chaparro-Gutierrez, Jenny J. [1 ,2 ]
Wasserman, Moises [1 ]
机构
[1] Univ Nacl Colombia, Fac Ciencias, Lab Invest Basicas Bioquim, Bogota, Colombia
[2] Univ Antioquia, Escuela Med Vet, Fac Ciencias Agr, Medellin, Colombia
关键词
protozoan; thermic shock protein; ubiquitin; PROTEASOME INHIBITION; LAMBLIA; CELLS; ENCYSTATION; MECHANISMS; INDUCTION;
D O I
暂无
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Previous studies have demonstrated the existence and expression of genes essential to the process of protein ubiquitination in Giardia intestinalis, indicating that the ubiquitin-proteasome system may be involved in the degradation of proteins during its life cycle of the parasite. In this study, purification of ubiquitin was conducted from protein extracts of G. intestinalis trophozoites. Then, an anti-ubiquitin specific antibody was obtained to standardize an assay for the detection and evaluation of ubiquitination patterns. Finally, HSP90 was identified as an ubiquitinated protein in this protozoan. This post-translational modification could have regulatory effects associated with the functionality of the protein or its turnover to regulate key molecular events during the parasite's life cycle.
引用
收藏
页码:107 / 115
页数:9
相关论文
共 50 条
  • [21] Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
    Sitko, Krzysztof
    Bednarek, Marta
    Mantej, Jagoda
    Trzeciak, Magdalena
    Tukaj, Stefan
    CELL STRESS & CHAPERONES, 2021, 26 (06): : 1001 - 1007
  • [22] Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
    Krzysztof Sitko
    Marta Bednarek
    Jagoda Mantej
    Magdalena Trzeciak
    Stefan Tukaj
    Cell Stress and Chaperones, 2021, 26 : 1001 - 1007
  • [23] Overview: Translating Hsp90 Biology into Hsp90 Drugs
    Workman, Paul
    CURRENT CANCER DRUG TARGETS, 2003, 3 (05) : 297 - 300
  • [24] Old and New Approaches to Target the Hsp90 Chaperone
    Sanchez, Jackee
    Carter, Trever R.
    Cohen, Mark S.
    Blagg, Brian S.
    CURRENT CANCER DRUG TARGETS, 2020, 20 (04) : 253 - 270
  • [25] Hsp90: Still a viable target in prostate cancer
    Centenera, Margaret M.
    Fitzpatrick, Alyssa K.
    Tilley, Wayne D.
    Butler, Lisa M.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2013, 1835 (02): : 211 - 218
  • [26] Hsp90: an emerging target for breast cancer therapy
    Beliakoff, J
    Whitesell, L
    ANTI-CANCER DRUGS, 2004, 15 (07) : 651 - 662
  • [27] Hsp90 as a Potential Therapeutic Target in Retinal Disease
    Aguila, Monica
    Cheetham, Michael E.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2016, 854 : 161 - 167
  • [28] Mitochondria HSP90: the target to inactivate in cancer therapy?
    Didelot, Celine
    Garrido, Carmen
    M S-MEDECINE SCIENCES, 2008, 24 (04): : 363 - 364
  • [29] Molecular Chaperone Hsp90 Is a Therapeutic Target for Noroviruses
    Vashist, Surender
    Urena, Luis
    Gonzalez-Hernandez, Mariam B.
    Choi, Jayoung
    de Rougemont, Alexis
    Rocha-Pereira, Joana
    Neyts, Johan
    Hwang, Seungmin
    Wobus, Christiane E.
    Goodfellow, Ian
    JOURNAL OF VIROLOGY, 2015, 89 (12) : 6352 - 6363
  • [30] Extracellular HSP90: An Emerging Target for Cancer Therapy
    Sidera, Katerina
    Patsavoudi, Evangelia
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2009, 4 (01) : 51 - 58